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List of Abbreviations

9-EtGH

9-ethylguanine

bp

base pairs

C

concentration

CT
DNA

calf thymus

Dnase I

deoxyribonuclease I

ciA

adenine

dC

cytosine

dG

guamne

dT

thymine

DtolF

ditolyl formamidinare

E. coli

Escherichia coli

EDTA

ethylenediaminetetraacetic acid

GFAAS

graphite furnace atomic absorption spectroscopy

HPLC

high performance liquid chromatography

LDlo

lethal dose for 10 percent of subjects

LDso

lethal dose for 50 percent of subjects

MS

mass spectrometry

MWCO

molecular weight cut off

Phen

phenyl

ppb

parts per billion

~

ratio of moles of bound rhodium to moles of DNA base pairs

Rf

ratio of moles of free metal added to original reaction mixture to

deoxyribonucleic acid

moles of DNA base pairs

RNA

ribonucleic acid

UV-vis

ultraviolet-visible spectroscopy
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Introduction
In 1952, Dwyer and coworkers began testing a series of metal complexes for
potential inhibition of cancer cell proliferation in animals.(l] The complexes tested were
unsu itable for such studies due to their high toxicity. Therefore, no further work was
done on the project.

However, in 1965 , Rosenberg and coworkers revisited the

possibility of potential metal-based drugs. Serendipitously, they discovered that cis
diamminedichloroplatinum(lJ) (cisplatin) inhibits cell division in E. coJi.[2]

Further

studies of this and other platinum compounds revealed inhibition of tumor cell lines
sarcoma 180 and leukemia LI2lO in rnice.j l ] Cisplatin was approved by the Food and
Drug Administration in 1970 as a chemical chemotherapeutic agent in the treatment of
cancer. The drug has primarily been used in the treatment of testicular and ovarian
cancers, although the powerful chemotherapeutic properties of the compound indicate use
against a variety of other cancers.[3] The toxicity of ,this compound, however, warrants
the development of other metal-based potential anti tumor agents.
The success of cisplatin, a transition-metal-based chemotherapeutic, opened the
doors to a host of research on the antitumor
effects of other transition-metal complexes.
Beginn ing in the 1970s, researchers looked to
rhodium for potential use in antitumor
complexes.

Dirhodium complexes with

bridg ing equatorial ligands (Figure I) were the
primary focus for th is research.

The

..

overwhelming majority of these complexes

Figure J. In the basic dirhodium
carboxylate structure R CH J (acetate)
(Rhla) . CH 2CR j (propionate) (RbJb).
CH 2CH2CH J (butyrate) (Rh l c) and L
solvent (rhO or CH 3CN)

=

=
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were dirhodium(II) carboxylate complexes, containing two rhodium(II) centers, four
equatorial ligands in a lantern formation around the metal center, and an axial ligand on
either end. The family of complexes in Figure 1 will be referred to as dirhodium(II)
carboxylate complexes. The dirhodium centers are each d7 with a metal-metal bond
between them . Although d1 atoms are paramagnetic, the two unpaired electrons pair to
make the complex diamagnetic. The basic formula of the dirhodium(lI) carboxylate
complexes is Rh 2(RC OO)4( L)2 with R being methyl, ethyl, propyl, or butyl groups and L
being water or the solvent in which the complex was crystalized. Of these dirbodium(II)
carboxylate complexes, our research focuses on Rb la and two other similar complexes
Rh2 and Rh3 (Figure 2). Rh2 is an activated form of Rh la, with four acetonitrile groups
in place of two of the bidentate acetate ligands.

R h 3 is similar to Rh l a, with

trifluoromethyl groups in place of the methyl groups on the acetate ligands.

Figure 2. The complexes studied in these experiments are Rh2(CH3COOMH20h
(Rbla), (Rh 2 (CH3COOhCCH3 CN) 6](BF4h (Rb2) , and Rh2(CF3COO)4(H20h (Rh3)

Research in this area throughout the 1970s varied from in vitro toxicity studies to
specific binding assays. In 1974, Erck and coworkers presented LD 10 and LDso values
for an array of dirhodium(lI) carboxylate complexes.[4] Studies of mouse survival rates
indicated anticancer activity by Rhla . In a similar study, Bear and coworkers (1975)
found increasing antitumor activity of the dirhodium(I1) carboxylate complexes Rhla,
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Rh Ib, Rhlc, respectively.[5] Hall and coworkers (1980) reported that, although the
dirhodiwn(ll) carboxylate complexes show some antitumor activity, their efficacy is not
comparable to that of platinum-based drugs.[6] The researchers concluded that no further
study of dirhodium(Il) carboxylate complexes as antitumor agents was warranted. The
studies by Erck and coworkers (1974) and Bear and coworkers (1975) concluded that

Rhla was involved in the inhibition of DNA polymerase activity. Erck and coworkers
found the inhibition of DNA polymerase to be significantly greater than the inhibition of
RN A polymerase.
Both reports by Erck and coworkers (1974) and Bear and coworkers (1975)
included the

14

C labeling of the carboxylate ligands to look at rhodium compound

binding to a variety of potential targets, including native double stranded (ds) DNA,
denatured DNA, poly-adenine (cIA), -thymine (dT), -guanine (dO), and -<;y1osine (dC)
strands, and a number of potential enzyme targets.

The assays indicated that the

complexes were not binding to native calf thymus DNA, but did bind to denatured calf
thymus DNA and bound preferentially to poly-d.A strands. In both studies, researchers
neglected to look at the rhodium directly. The use of 14C labeled carboxylate groups did
not take into account the possibility of acetate ligand displacement by solvent or by
substrate.
A 1972 abstract by Hughes and coworkers indicated that Rbla binds strongly to
DNA to give a blue rhodium-DNA complex, although they did not specify the type of
DNA used in the experiment.[7] In 1976 Erck and coworkers looked at incorporation of
14C and rhodium into mouse organs via radioactivity measurements and graphite furnace
atomic absorbtion spectroscopy (GFAAS) zespecrively. Swiss mice implanted with

to

Erlich ascite tumors were injected with 14C labeled Rb 1a. Exhalation data of 14C02
indicated that the Rh 1a acetate ligands were exchanging to give free acetate ions that
were converted to 14C Ch and exhaled. Total rhodium concentrations and 14C levels were
also measured in different tissues. Analysis of tumor cells indicated that some rhodium
and some 14C were incorporated into the cell. This direct measurement of rhodium is
essential to determine the binding targets of the rhodium complexes. This study was
pivotal in that it indicated the presence of rhodium within the tumor cell, which allows
for DNA-binding as a potential hypothesis for drug activity.
The study by Bear and coworkers in 1975 also looked at the binding mode of
dirhodium(II) carboxylate complexes. By looking at the color change using ultraviolet
visible (UV -vis) spectroscopy upon binding, researchers claimed that Rbla binds to
single-stranded polynucleotides in an axial mode.

The original blue-green rhodium

complex turned pink, which was suggested to indicate adduct formation through
nitrogen-rhodium coordination. In addition to identifying an axial-binding mode, Bear
and coworkers looked at the rhodium dependent inhibition of DNA polymerase I in the
presence of poly-da/dT and poly-dO/dC strands. They saw increased DNA polymerase I
inhibition in the presence of poly-dA/dT over poly-dG/dC (83.9% and 55.7%
respectively). They argue that rhodium-binding to the template, substrate, and enzyme is
possible in the case of poly-dNdT but that only binding to the enzyme is possible in the
case of poly-dfi/dC. These conclusions indicate that there is rhodium-binding to ds
DNA, although the duplexes studied are not naturally oecuning.
A 1976 study by Howard and coworkers of the dirhodium(Il) carboxylate
complexes noted that enzymes with cysteine residues were irreversibly inhibited by the
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rhodium complexes while those enzymes without a thiol group in or near the active site
were not affected.[8] The irreversible binding was thought to cause breakdown of the
lantern cage structure of the rhodium complexes. If complex activity comes from
binding to other substrates, the binding to nonspecific cysteine residues of other enzymes
would lower the activity. Studies by Bear and coworkers in 1978 indicated that this
breakdown of the lantern cage structure could be slowed by the addition of the
competitive substrate poly-dA.[9] Injections of solutions with a mixture of poly-dA and
Rh lb in mice with Erlich ascite tumors resulted in a lifespan increase over controls
injected with a solution containing only Rhlb. Poly-dA:Rh Ib ratios of 10: I and 20: I in
these studies resulted in lifespan increases of almost 300 percent. Bear and coworkers
concluded that poly-dA stabilized Rblb via axial binding, therefore slowing its
deactivation by reaction with enzyme thiol groups. Injections of the thiol containing
competitor glutathione at fifteen minutes after a lethal injection of a Rh Ib solution was
found to have similar effect. The glutathione detoxified the drug by competing for the
sulfhydryl binding and enhanced the tumor activity of the drug by keeping the compound
in a putative precursor form . Reactions competing for Rh Ib over the thiol group appear
to increase the amount time the compouod remains in an active form. In reference to ds
DNA binding, if rhodium-DNA binding is slower to form than rhodium-thiol binding,
having the active complex available to the DNA substrate

00

a longer timescale may

increase the likelihood that DNA binding will occur. The increased life span data and
toxicity study data concur with this mode of antitumor activity.
As the carbon chain on dirhodium(II) carboxylate complex ligands is extended,
the lipophiliciry of the molecule changes... Acetate is less lipophilic than propionate
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which is less lipophilic than butyrate. A 1976 study by Sherwood and coworkers
indicated that the lipophilicity of different dirhodium(II) carboxylate complex equatorial
ligands correlated with drug uptake by the cell.[ 10]

Increased lipophilicity meant

decreased solubility, but also increased cellular toxicity and antitumor activity.
Ultimately, the uptake of compound into the cells increases as the partition coefficient
(lipophilicity) of the rhodium compound increases.
Tn 1980, Rao and coworkers studied the cell cycle effects of Rbl c on HeLa
cells.[ 11] Rao and coworkers found Rb I c to be extremely cytotoxic at relatively low
concentrations of 0.8 roM. The compound retarded cell cycle progression, primarily by
inhibition of DNA synthesis and, to a lesser extent, by inhibition of protein synthesis.
The previous studies by Bear and coworkers (1975) indicating that rhodium(II)
complexes did not bind to DNA suggested that the DNA synthesis inhibition was due to
enzyme inhibition rather than direct interaction with DNA. Experiments done by Rae
and coworkers measuring chromosomal aberrations indicated that DNA is not the
primary target for Rhlc.[11] It was hypothesized that inhibition of DNA synthesis
enzymes slows the replication process, thereby increasing aberrations due to nicks by
endonucleases which occur when the ds DNA is left open in several regions of the
chromosome.
Through the 1980s and early 19905 there was a lull in the research pertaining to
dirhodium complex antitumor activity. Then, beginning in the mid 19905, Kim Dunbar
and others took another look at the possibility of caged metal complexes binding to DNA.
A 1994 study by Reibscheid and coworkers indicated that Erlich ascite tumor
bearing mice treated with Rh2 in vivo showed increased survival rates over controls. [ 12]
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The group also performed in vitro experiments. Controls were treated with acetone in
place of Rb2 . The results indicated that Rb2 induced a higher cell death rate in cancer
cells than acetone controls. At the same time, Dunbar and coworkers published crystal
structures of dirhodium complexes bound to DNA nucleoside analogs showing that Rb3
had two of its four tritluoroacetate ligands displaced by the N7/06 positions of two 9
ethylguanine molecules in a head-to-tail arrangement (Figure 3) .[ 13]

Figure 3. Rh3 with two trifluoroacetate ligands dispaced by two 9
ethylguanine bases in a head-to-tail arrangement.

Following these 1994 structural studies, in 1999 Catalan and coworkers
crystallized [Rh 2(DtoIF)2(9-EtGH)2CCH3CN)][BF4 ] with tbe 9-etbylguanine bound in an
equatorial fashion.] 14] Catalan and coworkers rationalized previous claims that guanine
could not bind to the dirhodium(II) carboxylate complexes axially by showing how the
N6 position of adenine but not the 07 position of guanine can lead to hydrogen-bonding
stabilization of axial bonding interactions. This rationale could account for the increased
axial poly-dA binding seen by Erck and coworkers and Bear and coworkers in the
1970s.[4, 5]
Sorasaenee and coworkers have shown that Rh l a binds to calf thymus DNA via
UV absorption ritration.j l S] Transcription inhibition was found for both Rbla and for
[Rh2(CH 3COOh(phenhlCh complexes although they concluded that the mechanism of
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transcription inhibition is likely due to a rhodium compound interaction with the RNA
polymerase rather than strong interactions with the DNA template.
To this point, no research has directly quantitated the amount of rhodium that
binds to ds DNA in solutions of dirhodium lantern derivative complexes and ds DNA.
Although the work by Bear and coworkers in 1976 looked directly at rhodium, it did not
look at ds DNA binding. All other DNA binding experiments used

14 C

radiolabeling

which followed the methyl, propyl or butyl carbons of the acetate, propionate or butyrate
ligands, respectively. Our work looks directly at the binding of rhodium to DNA via
graphite furnace atomic absorption spectroscopy (OF AAS). We studied the interaction of
complexes Rhla, Rh2, and Rh3 with ds DNA at various ratios of compound to DNA
base pairs (bp). We saw different degrees of DNA binding and were able to extract
kinetic data from the binding curves obtained. Further work is in progress to examine the
adducts formed by these complexes.

Enzymatic digestions coupled with high

performance liquid chromatography (HPLC) and mass spectrometry (MS) will allow us
to answer a number of questions about the adducts. We hope to obtain information about
the size of the adducts, the DNA bases bound by the rhodium and the changes in
coordination of the dirhodium core.

Materials and Metbods
Rhodium and DNA Solutions. All dirhodium complexes were provided by collaborators
at Texas A&M University (K. R . Dunbar and H. T. Chifotides) as crystalline solids.
Molecular weights had been previously determined by mass spectrometry (Rbt a

mJz=478, Rh2 mJz:::744, Rh3 rn/z= 77 0). Complexes were shipped as dry solids and
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stored in a dessicator until use. Immediately prior to use the complexes were dissolved in
deionized water and diluted appropriately. Calf thymus (CT) DNA obtained from Sigma
(part no. D-150 I) was dissolved in a 1.5 roM sodium phosphate buffer at pH 6 with 15

mM NaCI, and filtered through a 0.45 micron filter before use . Stock and sample DNA
concentrations were obtained using a Hewlett-Packard 8452A UV-vis spectrophotometer.
Absorption of the stock and sample solutions were measured at 260 nm in a 1 cm quartz
cuvette with deionized water used as the blank. The concentrations were determined by
the following formula[ 16]: C (mg/ml)

=A2(,oI0.020.

To convert to M base pairs (bp), the

average molecular weight of a base pair was assumed to be 660 g/mol.

Rh-DNA Binding. The CT-DNA concentration in all binding experiments was 200 mM
in bp. Rhodium complex concentrations in reactions ranged from 1.81 to 124 mM .
Controls containing only DNA or only rhodium complex were prepared and worked up
concurrently with the sample solutions. Binding experiments were carried out in 1 roM
sodium phosphate buffer at pH 6.9 with 3 roM sodium chloride. All experiments were
incubated at 37 [C in the dark. Aliquots of 1 mL volume were taken and worked up over
the course of the incubation. Each 1 mL aliquot was diluted 10-fold with 0.2 M NaCI
aliquot and immediately filtered with a centrifugal filter (Millipore Ultrafree, 30,000
MWCO) to remove unbound rhodium complex . NaC! was added in order to disrupt any
electrostatic interactions between positively charged complexes (Rh2 is charged, while
Rhla and Rb3 could potentially exchange ligands with solvent molecules to form
charged species) and negatively-charged DNA. In two subsequent spins, the retentate
was diluted 1o-fold with deionized water each time.
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Rh Metal Quantitation. Rhodium metal concentrations were determined by graphite
furnace atomic absorption spectroscopy (GFAAS) using a Thermo Jarrell Ash Smith
Hieftje 22 atomic absorption spectrophotometer and Furnace Atomizer 188 with a
rhodium lamp. The background current of the rhodium lamp is 3 milliamps. Absorbance
was monitored at 343 nm. Multielement Solution 3 metal standard was obtained from
Claritas (catalog no. CLMS-3) in 10% HCI / 1% HNO) and diluted with a 10% HCI / 1%
HNO) stock solution to obtain standard curves (30 ppb to 1200 ppb) before data
collection. Sample injection volumes were 25 mL and sample concentrations were
within a range of -50-1200 ppb rhodium. The temperature program for the GF AA can be
found in Appendix 1.

Enzymatic Digestions. Metal-modified and control DNA samples were enzymatically
digested to nucleosides. Samples containing 10 mg DNA were incubated at 37 jC with 5
units of DNase I (Sigma, EC 3.1.21.1) and 1 unit of PI nuclease (Sigma., EC 3.1.30.1) in
1 M sodium acetate pH 5.0 with 100 mM magnesium chloride for 16-20 hours in a total
volume of 50 mL.

A 15 mL aliquot of the original digestion was removed and the

remaining portion was stored at -4 iC. To the 15 mL aliquot was then added 2 units of
alkaline phosphatase (Sigma., EC 3.1.3.1) and 15 mL of a pH 8.8 solution of 0.2 M Tris
buffer with 0.2 roM EDTA added prior to incubation at 37 iC for ~8 hours.

HPLC Separations. Approximately 1 mg of DNA was diluted up to 200 mL for injection
onto a Vydac CI8 reverse-phase column (part #27324) with a guard column. A pH 6, 0.1
M NH.iOAc buffer (A) and a pH 6, 50% 0.1 M NH 40Ac / 50% CH)CN buffer (B) at a
flow rate of I mUmin were used on a \\4aters 501 HPLC pump with an automated
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gradient controller.

Peaks were detected with a Waters Lambda-Max Model 481

spectrophotometer at an absorbaoce of 260 om. Linear gradients of A and B were used
over 45 minutes (Figure 4).
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Results
Figure 5 shows DNA binding curve data generated for reactions of three rhodium
complexes with DNA. Solutions of Rh ta, Rb2, and Rb3 and ds DNA were incubated
over 72 hours in a buffer solution. The formal reaction ratio (Rr) is the molar ratio of
rhodium complex to DNA bp in the initial reaction mixture. The R{ for the Rhla
reaction was 0.62, or approximately 6 molecules of Rh 1a to every 10 base pairs of DN A.
Rj values for Rh2 and Rb3 were 0.072 and 0.0091, respectively. Rb values are the molar
ratio of bound rhodium to the total DNA bp measured at each respective time point.
Calculations of RlIRr suggest the relative amount of ds DNA-bound rhodium complex at
a given reaction time . Ail three complexes exhibit some amount of binding to ds DNA.
Approximately 100% of the Rh2 and Rh3 bind to DNA within 1 to 2 days, while less
than 10% of the Rh I a complex binds to DNA over the same period. Figure 6 shows
DNA-binding curve data generated from rhodium-DNA reactions at three different initial
Rb2 concentrations.

At Rf values of 0.0068, 0.036 and 0.076, 5.5%, 81% and

approximately 100% of the Rh2 bound to ds DNA, respectively.
Table 1 shows rate data for the formation of DNA ad ducts with Rb la, Rh2, or
Rh3 . The rate constant for Rb2 at Rr=0.0068 was difficult to calculate because the first
measurements points had negative values and it is not possible to take the natural log of a
negative number. Standards were in a standard diluent solution, while samples were in a
deionized water solution. This discrepancy could shift the GFAA signal. Since the
concentration of DN A bp was in great excess, the initial formation reaction was assumed
to be first order in rhodium complex and almost no complex is covalently bound at the
start of the reaction. Rate constants were calculated using the equation: In(Rb)

:::

k

* t. A
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linear fit to a plot of In R, versus time gave the rate constant of the reaction (k) as the
slope. The initial slope of Rb versus time was calculated as the initial rate of each
reaction. Standard deviations were calculated for both the rate constants and tbe initial
rates using Linest in Microsoft Excel. Rate constants and initial rates increase in the
order Rh la < Rb2 < Rh3. Rate constants for the reactions run at the two higher
concentrations of Rb2 are close in value. As the initial concentration Rh2 increased, the
initial rate of reaction increased linearly (Figure 7).
Platinum -DNA adducts have been indentified via HPLC separation of enzymatic
DNA digestion in previous work.[3] Adducts of rhodium complexes and 9-ethylguanine
were purified using HPLC separation. [17] Enzyme digestion separations will allow us to
isolate rhodium-bound DNA digestion products. HPLC data are presented in Figure 8 for
a mixture of the four nucleosides (Figure Sa), for Rb3 modified DNA (Figure 8b) and for
the enzymatic digestion of control CT-DNA (Figure 8e), respectively. Figure 8a has 5
peaks while band c each have 6 peaks. Table 2 shows the peak times for each of the
three traces.

..
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...... Rh J a (R -0.62) .....- Rh 2 (Rf==O.072 ) .....- Rb

~
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111:' 1 \'aCI butler 31pH 6 9. All Rtand Rb values arc experimental ly determined.
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Table t. Tabulation of rate dam for reaction of RbI a, Rh2 or Rh3 with cis DNA at various Rj values.

Rate
Complex

R{

Rhla
Rh2
Rh2
Rh2
Rh3

0.62
0.0068
0.036
0.076
0.0018

Constant (k)
0.037
0.0053
0.22
0.33
0.25

1 Standard
Deviation
0.002
0.01
0.03
0.09
0 .04

..

Initial Rate
(sec· l )
0.00070
0.0040
0.019
0.048
0.10

1 Standard
Deviation
0.0001
0.0004
0.0009
0.008
0.02
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Discussion
Binding of dirhodium(Il) lantern complexes to ds DNA has been a subject of
confusion in the literature. Much of the earlier confusion stemmed from assumptions
about tbe nature of the binding and the stability of lantern complexes. Although data
from 1976 indicated the breakdown of lantern complexes upon injection into Swiss mice,
this did not alleviate confusion about binding modes or the possibility of binding to ds
DNA. Recent data have shown that the lantern complexes can react by the substitution of
two of the bidentate ligands by N7/06 of guanine or the N71N6 of adenine in nucleoside
analogs and short nucleotides, but have not shown direct evidence of ds DNA
binding.[13,17]
One important key in determining the binding of the dirhodium(lI) lantern
complexes to DNA involves directly studying the fate of the rhodium center.

If

radiolaheled ligands are displaced, it is not possible to fully characterize metal-DNA
binding if ligands are used as the tracer for the complex. Our studies look directly at the
concentrations of rhodium that remained after filtering Don-covalently bound rhodium
complex out of the rhodium-DNA reactions. Rh2 is the only complex that is charged
while the others are neutral. Exchange of acetate or trifluoroacetate ligands from any of
the three rhodium complexes by an uncharged ligand (such as water) would increase the
charge on the complex by + I. Cationic complexes could electrostatically bind the DNA
polyanion. A ten-fold dilution with a 0.2 M NaCI solution followed by filtering was used
to minimize carryover from any electrostatic interactions between the positively charged

rhodium complexes and negatively charged DNA. The remaining two dilutions and
filtration steps were done with deionized, water to remove and dilute free rhodium
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complex to a concentration below tbe detection limit of the OF AAS . Therefore, rhodium
detected in the final filtered DNA aliquots is assumed to be covalently bound .
There are three possible types of DNA binding that can occur. Covalent binding
is the most probable mode of binding, as rhodium metal centers have been shown to bind
nucleosides and small nucleotides in a covalent fasion. Electrostatic binding is unlikely,
since NaCI was used to disrupt any electrostatic interactions. Intercalation is usually
involved for a complex when one or more of the ligands have a planar aromatic moiety
that can disrupt the helix by slipping between the stacked bases. Because the ligands on
Rh Ia, Rh2, and Rh3 are not aromatic, intercalation is also not likely.
OUf

data (Figure 5) indicate rhodium binding to ds DNA for each of the three

complexes studied. Rhla shows the lowest reactivity with ds DNA, with approximately
7 percent of the total Rh l a bound to DNA after 72 hours ofreaction. A high Revalue for
Rh 1a was appropriate because little to no binding was seen at lower R f ratios. Both Rb2
and Rh3 reached approximately 100 percent binding in the 72 hour time period at much
lower R, values.
The data indicate that Rh 1a does not bind as quickly or to the same extent as the
other two complexes. This is consistent with the structures of the complexes. If Rh Ia is
the least activated complex, we would expect the initial rate of binding to be much
slower. Even at a concentration more than double that of Rh2 and Rh3 , the initial rate of
binding is much slower (Table I). The initial rate of binding of Rb3 is greater than Rb2
indicating that the Rh3 is the most activated complex (Table 1).
These binding rates are consistent with predictions based on the structures of the
complexes and assumptions that the rhodium binding to ds DNA would be in an
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equatorial mode. Rhla has four bidentate acetate ligands around the dirhodium core, and
two axial waters which are reported to be easily exchangeable. [ 17] The Rh2 complex is
considered to be an activated form of the Rh l a: two of the bidentate acetate ligands have
been replaced by four acetonitrile ligands; the axial waters have also been replaced by
acetonitrile ligands. The removal of the two bidentate acetate ligands has the potential to
increase the rate of equatorial binding. In order for a nucleophilic atom to bind to one of
the rhodium centers, it must simply displace one of the acetonitrile groups. Binding of
one of the potential binding-sites on a DNA base brings the second nucleophilic site in
close proximity to the second rhodium metal center where it competes for the equatorial
position on tbe rhodium. If an acetate ligand is being displaced, the acetate oxygen atom
that is displaced first remains in the vicinity and continues to compete for the original
binding site as long as the other oxygen atom remains bound to the metal center. A
second nucleophilic site on the DNA base then competes for the other binding site. There
is competition between the closing rates of the acetate ligand and the N7 or 06 of
guanine or another DNA base. This competition between the DNA base and the acetate
ligand for the rhodium site could slow the displacement of acetate ligands on Rh l a, but
would not be present for the acetonitrile ligands on Rb2. The differences in entropy
between chelate binding and monodentate ligand binding are known as the chelate effect .
Chelate ligands have greater entropy terms for binding than monodentate ligands. The
close vicinity of the second binding site of the Rhla acetate will make the entropy term
for rebinding acetate higher than for Rh2, where the acetonitrile ligands can diffuse away
from the reaction in solution.

The entropy term for the DNA base will be the same for
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both Rhla and Rh2 making the chelate effect the most important difference in the
entropy of the two systems.
Rb3 has four trifluoroacetate bidentate ligands and two axial waters.

The

trifluorornethyl group is highly electron withdrawing. The electron density of the
rhodium-oxygen bond and the electrons on the oxygen will be pulled toward f1uorines.
This will make the rhodium-ligand bond longer and weaker, allowing easier displacement
of a trifluoroacetate ligand than an acetate ligand. The initial rate of Rb3 is faster than
both Rbla and Rh2. The chelate effect contributes to the entropy term in reactions of

Rhla and Rh3.

Yet the highly electron withdrawing groups of Rh3 will make the

triflouoroacetate ligands more easily displaced than the acetate ligands of Rh 1a. Rh2
does not have the chelate effect. Therefore, further work could be done using molecular
modeling to look at bond length and strength between the trifuoroacetate ligand and
rhodium and between the acetonitrile ligand and rhodium.

A weak rhodium

trifluoroacetate bond on Rh3 decreases the entropy contribution of the chelate effect
because the whole ligand is quickly displaced, hence it is in the vicinity of the second
rhodium binding site for less time. This would increase the free energy term for the
reaction.

Similarly, if the rhodium-acetonitrile bond is stronger than the rhodium

trifluoroacetate bond, it could be more difficult to displace the acetonitrile, decreasing the
free energy term for the reaction. If the chelate effect is decreased for Rh3, and the
rhodium-oxygen bond strengths are greater for Rh2 and less for Rh3, it is possible that
the displacement of Rh3 will be more thermodynamically favorable. This hypothesis is
consistent with the greater initial rate of reaction for Rh3.
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Our data (Figure 6) also indicate that the initial rate and amount of DNA-binding
of Rb2 is dependent on the Rr. DNA-binding data for Rb2 at the lowest R; (0.0068)
show tbat only 5.5 percent of the rhodium is bound to ds DNA after 72 hours, while at an
R, value of 0.036 81 percent ds DNA-binding is observed. At the highest reaction R,

(0.076), -100 percent ds DNA-binding is seen. These data indicate that a greater
rhodium to DNA bp ratio (Rj) increases the total amount of rhodium that can bind. The
initial rate data indicate that greater concentrations of rhodium increase the initial rate of
reaction. A plot of Rr versus initial rate of reaction is linear (R
the formation reaction is fist order (Figure 7).

2=0.992),

indicating that

Rate constants calculated for the three

Rh2 reactions should be the same, as rate constants do not depend on concentration. The
rate constant calculation for the reaction at the lowest R r (0.0068) was calculated without
all of the data points because some of the points were negative (and it is not possible to
take the natural log of a negative number) and therefore is suspect. Rate constants for the
reactions at the two other Rr values (0.036 and 0.076), however, are both within 1
standard deviation of each other.
Although our studies have not yet identified the mode(s) of rhodium-DNA
interaction in our reaction products, we have sufficient data to support covalent bonding
of Rb2 to DNA. Confirming the mode(s) of binding, however, cannot be determined by
our methods. There are four factors that indicate covalent binding. To eliminate the
potential for electrostatic interactions, we used high concentrations of the sodium cation
to compete away excess charged rhodium complex. The filtration steps also diluted out

the unbound rhodium complex. The total amount of DNA-bound rhodium increased over
time and with increased Rh2 concentratioa. If the DNA-binding was electrostatic, there
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would not be an increase in

DNA~binding

with increased time. We see this increase in

binding over time for Rh l a, Rh2, and Rh3 indicating that covalent binding may be the
mode of binding for all three compounds.
Figures 6 show HPLC data for a mixture of nucleosides (trace A), a digested Rh3
DNA adduct sample (trace B) and a digested CT-DNA control (trace C). The three traces
all have the same enzymeJbuffer injection peaks as seen in our enzyme-buffer control
(data not shown) (Table 2), at about 2.7 to 2 8 minutes. Four other peaks are also
identified for these three samples (at approximately 6, 17, 20 and 21 minutes) and are
expected to be unmodified nucleosides: dC, dG, T and dA. In order to determine the
identity of each peak injections of each pure nucleoside must be done under the same
separation conditions. From literature reports of data collected on the same standards
under the same conditions, the expected order of nucleosides is dC at -6 minutes, dG at

-17 minutes, T at -20 minutes and cIA at '" 21 minutes. An additional peak is observed
in the digestions of Rh3-modified DNA. Although we hoped to see additional peaks
indicating rhodium-modified nucleosides, this peak was also observed in the DNA only
digestion . Therefore, it is believed that this peak results from an as yet uncharacterized
modified version of dA produced by overdigestion with PI nuclease .] 18]

Further

digestion experiments are necessary to confirm this hypothesis. Two questions which
must be addressed are how stable rhodium-DNA adducts are to both the digestion
conditions and to the separation conditions. Asara et at. have used HPLC to purify a
rhodium-bound l l-rner, indicating that rhodium-DNA adducts can be stable under HPLC
conditions.] 17] OF AA can be used to confirm the presence of rhodium in digestion
peaks isolated by HPLC. Further experirfients with digestion enzyme concentrations,
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incubation times, detection wavelength, and separation gradients must be done to search
for the potential rhodium-modified products by HPLC.

Conclusions
Binding to ds DNA was seen for Rhla, Rb2, and Rh3. We have found that the
amount of ds DNA binding and initial rate of ds DNA binding are dependent on the
initial concentration of rhodium complex.
inconclusive at this time.

HPLC data of DNA digestions are

Further work with the Rb data needs to include error

calculation, in reference to both DNA concentration measurements and rhodium
concentration measurements.

In the event that a rhodium-DNA adduct can be isolated,

mass spectral data should help to elucidate base preference and determine if any ligands
are displaced in the reaction of each complex with ds DNA. Molecular modeling studies
examining the feasibility of both equatorial and axial binding of ds DNA to rhodium
complexes on may also help understand potential DNA binding modes and reaction
mechanisms.
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Appendix I
GF AA temperature program

Dry
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Temp
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